TLDR Phillip Securities gives Micron Buy rating with $500 price target on strong HBM demand Analyst expects Micron to steal SK Hynix market share when HBM4 rampsTLDR Phillip Securities gives Micron Buy rating with $500 price target on strong HBM demand Analyst expects Micron to steal SK Hynix market share when HBM4 ramps

Micron (MU) Stock: Phillip Securities Sets $500 Price Target on HBM Demand

2026/02/02 22:12
3 min read

TLDR

  • Phillip Securities gives Micron Buy rating with $500 price target on strong HBM demand
  • Analyst expects Micron to steal SK Hynix market share when HBM4 ramps post-Q2
  • Stock drops 1% Monday, down 5% Friday despite bullish analyst call
  • Micron commits $24 billion to Singapore manufacturing expansion over 10 years
  • 38 of 44 Wall Street analysts rate stock Buy or higher

Micron Technology shares continued sliding Monday despite fresh analyst optimism. The stock fell roughly 1% after dropping nearly 5% Friday.


MU Stock Card
Micron Technology, Inc., MU

Phillip Securities kicked off coverage with a Buy rating and $500 price target. Analyst Yik Ban Chong sees roughly 21% upside potential from current levels.

The bullish stance centers on Micron’s high bandwidth memory products. These chips face surging demand from AI data centers and advanced computing needs.

Chong believes Micron will capture market share from industry leader SK Hynix. The shift should materialize when Micron’s HBM4 memory hits full production after Q2.

Why Investors Aren’t Buying the Rally

The negative price action seems odd given the positive analyst coverage. But investors appear to be taking profits after massive gains.

Micron stock jumped over 45% in January alone. Shares rocketed 240% throughout 2025. The pullback may simply reflect natural consolidation.

The company just announced a major manufacturing expansion. Micron plans to invest $24 billion in Singapore over the next decade.

Mizuho responded by lifting its price target to $480 from $390. The firm kept its Outperform rating intact. William Blair cautioned the expansion won’t boost near-term results.

Wall Street Remains Confident

Analyst support for Micron stays strong across the board. Out of 44 analysts tracking the stock, 38 rate it Buy or better. Four say Hold, and two recommend Sell.

The consensus price target lands at $361.85. That’s about 13% below Friday’s closing price. Phillip Securities’ $500 target ranks among Wall Street’s highest.

Memory chip stocks have caught fire on tight supply conditions. SanDisk crushed earnings estimates last week, fueling sector enthusiasm.

AI data center demand continues driving expectations for memory price increases. This dynamic should benefit Micron’s revenue and margins.

HBM4 Timeline Critical for Competition

Micron’s next-generation HBM4 production schedule will determine its competitive position. High bandwidth memory has become essential for AI workloads.

The company’s ability to ramp production efficiently matters for market share gains. Execution on the HBM4 rollout could justify the bullish price targets.

Phillip Securities’ $500 target reflects confidence in Micron’s HBM strategy. The firm expects the company to chip away at SK Hynix’s dominant position.

Mizuho’s raised target of $480 also signals optimism about long-term prospects. The Singapore investment strengthens Micron’s manufacturing foundation.

Memory pricing trends will play a key role in stock performance. Tight supply and strong AI demand support higher chip prices going forward.

The post Micron (MU) Stock: Phillip Securities Sets $500 Price Target on HBM Demand appeared first on Blockonomi.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

The Silver Price Doesn’t Look Real – And This Video Explains Why

The Silver Price Doesn’t Look Real – And This Video Explains Why

The Silver (XAG) price has been acting strange lately. Just when it looked like the market was settling down, a new argument started spreading fast: silver might
Share
Captainaltcoin2026/02/11 04:00
Will XRP Price Increase In September 2025?

Will XRP Price Increase In September 2025?

Ripple XRP is a cryptocurrency that primarily focuses on building a decentralised payments network to facilitate low-cost and cross-border transactions. It’s a native digital currency of the Ripple network, which works as a blockchain called the XRP Ledger (XRPL). It utilised a shared, distributed ledger to track account balances and transactions. What Do XRP Charts Reveal? […]
Share
Tronweekly2025/09/18 00:00
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11